Launched in 2017, Pathios is a drug discovery and development company focused on translating innovative science into new medicines. Pathios was founded by a team of experienced biotech and pharmaceutical industry professionals, entrepreneurs and clinicians, led by Chairman Tom McCarthy. The Company is initially focused on the development of modulators against G protein-coupled receptor, GPR65.

Clarendon Business Centre
57 Woodstock Rd
Oxford, OX2, 6HJ, UK

Email: info@pathiostherapeutics.com

Pathios Sygnature Press Release